147
Views
0
CrossRef citations to date
0
Altmetric
Research Papers

Prevalence of hypertension among individuals with diabetes and its determinants: evidences from the National Family Health Survey 2015–16, India

&
Pages 133-144 | Received 14 Dec 2021, Accepted 17 Apr 2022, Published online: 31 May 2022

References

  • Abdelbagi O, Musa IR, Musa SM, ALtigani SA, Adam I. 2021. Prevalence and associated factors of hypertension among adults with diabetes mellitus in northern Sudan: a cross-sectional study. BMC Cardiovasc Disord. 21(1):168.
  • Abdissa D, Kene K. 2020. Prevalence and determinants of hypertension among diabetic patients in Jimma University Medical Center, Southwest Ethiopia, 2019. Diabetes Metab Syndr Obes. 13:2317–2325.
  • Adeniyi OV, Yogeswaran P, Longo-Mbenza B, Ter Goon D. 2016. Uncontrolled hypertension and its determinants in patients with concomitant type 2 diabetes mellitus (T2DM) in rural South Africa. PLoS One. 11(3):e0150033.
  • Ahmad J. 2015. Management of diabetic nephropathy: recent progress and future perspective. Diabetes Metab Syndr. 9(4):343–358.
  • Akalu Y, Belsti Y. 2020. Hypertension and its associated factors among type 2 diabetes mellitus patients at Debre Tabor general hospital, northwest Ethiopia. Diabetes Metab Syndr Obes. 13:1621–1631.
  • Ali N, Akram R, Sheikh N, Sarker AR, Sultana M. 2019. Sex-specific prevalence, inequality and associated predictors of hypertension, diabetes, and comorbidity among Bangladeshi adults: results from a nationwide cross-sectional demographic and health survey. BMJ Open. 9(9):e029364.
  • Alqudah BM, Mahmoud H, Alhusamia S, Sh A, Al L, Alawneh ZE. 2017. Prevalence of hypertension among diabetic type 2 patients attending medical clinic at Prince Hashem Bin. Indian J Med Res Pharm Sci. 4(2017):47–54.
  • Arshad AR. 2014. Control of blood pressure in hypertensive patients with diabetes mellitus type 2. Pak Heart J. 47(2):78–83.
  • Avramescu A, Iancu MA, Dediu GN, Diaconu CC, Matei D. 2017. Relationship between hypertension and gender in patients with diabetes mellitus. J Hypertens. 35(2):e322.
  • Bahrey D, Gebremedhn G, Mariye T, Girmay A, Aberhe W, Hika A, Teklay G, Tasew H, et al. 2019. Prevalence and associated factors of chronic kidney disease among adult hypertensive patients in Tigray teaching hospitals: a cross-sectional study. BMC Res Notes. 12(1):562.
  • Bellou V, Belbasis L, Tzoulaki I, Evangelou E. 2018. Risk factors for type 2 diabetes mellitus: an exposure-wide umbrella review of meta-analyses. PLoS One. 13(3):e0194127.
  • Benowitz NL. 2003. Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment. Prog Cardiovasc Dis. 46(1):91–111.
  • Benowitz NL, Sharp DS. 1989. Inverse relation between serum cotinine concentration and blood pressure in cigarette smokers. Circulation. 80(5):1309–1312.
  • Berraho M, El Achhab Y, Benslimane A, El Rhazi K, Chikri M, Nejjari C. 2012. Hypertension and type 2 diabetes: a cross-sectional study in Morocco (EPIDIAM Study). Pan Afr Med J. 11:52.
  • Bhansali A, Dhandania VK, Deepa M, Anjana RM, Joshi SR, Joshi PP, Madhu SV, et al. 2015. Prevalence of and risk factors for hypertension in urban and rural India: The ICMR-INDIAB study. J Hum Hypertens. 29(3):204–209.
  • Bird Y, Lemstra M, Rogers M, Moraros J. 2015. The relationship between socioeconomic status/income and prevalence of diabetes and associated conditions: a cross-sectional population-based study in Saskatchewan, Canada. Int J Equity Health. 14(1):93–98.
  • Bollyky TJ, Templin T, Cohen M, Dieleman JL. 2017. Lower-income countries that face the most rapid shift in noncommunicable disease burden are also the least prepared. Health Affairs. 36(11):1866–1875.
  • Bommer C, Heesemann E, Sagalova V, Manne-Goehler J, Atun R, Bärnighausen T, Vollmer S. 2017. The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study. Lancet Diabetes Endocrinol. 5(6):423–430.
  • Boutayeb A. 2010. The burden of communicable and non-communicable diseases in developing countries. In: Preedy VR, Watson RR, editors. Handbook of disease burdens and quality of life measures. New York (NY): Springer; p. 531–546.
  • Brands MW, Manhiani MM. 2012. Sodium-retaining effect of insulin in diabetes. Am J Physiol Regul Integr Comp Physiol. 303(11):R1101–R1109.
  • Cade WT. 2008. Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther. 88(11):1322–1335.
  • Census of India. 2011. Provisional Population Totals, Paper 1 of 2011 India, Series-1. New Delhi: Office of the Registrar General and Census Commissioner.
  • Chen G, McAlister FA, Walker RL, Hemmelgarn BR, Campbell NR. 2011. Cardiovascular outcomes in Framingham participants with diabetes: the importance of blood pressure. Hypertension. 57(5):891–897.
  • Cheung BMY, Li C. 2012. Diabetes and hypertension: is there a common metabolic pathway? Curr Atheroscler Rep. 14(2):160–166.
  • Contreras F, Rivera M, Vasquez J, De la Parte MA, Velasco M. 2000. Diabetes and hypertension physiopathology and therapeutics. J Hum Hypertens. 14(S1):S26–S31.
  • de Boer IH, Bangalore S, Benetos A, Davis AM, Michos ED, Muntner P, Rossing P, et al. 2017. Diabetes and hypertension: a position statement by the American diabetes association. Diabetes Care. 40(9):1273–1284.
  • de Simone G, Devereux RB, Chinali M, Lee ET, Galloway JM, Barac A, Panza JA, Howard BV. 2010. Diabetes and incident heart failure in hypertensive and normotensive participants of the strong heart study. J Hypertens. 28(2):353–360.
  • Dokken BB. 2008. The pathophysiology of cardiovascular disease and diabetes: beyond blood pressure and lipids. Diabetes Spectr. 21(3):160–165.
  • El-Atat F, McFarlane SI, Sowers JR. 2004. Diabetes, hypertension, and cardiovascular derangements: pathophysiology and management. Curr Hypertens Rep. 6(3):215–223.
  • El-Hazmi MAF, Warsy AS. 2001. Association of hypertension and non-insulin-dependent diabetes mellitus in the Saudi population. Ann Saudi Med. 21(1–2):5–8.
  • Epstein M, Sowers JR. 1992. Diabetes mellitus and hypertension. Hypertension. 19(5):403–418.
  • Gerdts E, Regitz-Zagrosek V. 2019. Sex differences in cardiometabolic disorders. Nat Med. 25(11):1657–1666.
  • Gheorghe A, Griffiths U, Murphy A, Legido-Quigley H, Lamptey P, Perel P. 2018. The economic burden of cardiovascular disease and hypertension in low- and middle-income countries: a systematic review. BMC Public Health. 18(1):975.
  • Gupta A, Gupta R, Sharma KK, Lodha S, Achari V, Asirvatham AJ, Bhansali A, et al. 2014. Prevalence of diabetes and cardiovascular risk factors in middle-class urban participants in India. BMJ Open Diab Res Care. 2(1):e000048.
  • Gupta R, Xavier D. 2018. Hypertension: the most important non communicable disease risk factor in India. Indian Heart J. 70(4):565–572.
  • Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME. 2015. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res. 116(6):991–1006.
  • Husain K, Ansari RA, Ferder L. 2014. Alcohol-induced hypertension: mechanism and prevention. World J Cardiol. 6(5):245–252.
  • International Diabetes Federation. 2017. IDF Diabetes Atlas, 8th ed., London: IDF.
  • International Institute of Population Science (IIPS) and ICF. 2017. National Family Health Survey (NFHS-4). 2015–16, India. Mumbai: IIPS. [accessed 01 Novermber]. http://rchiips.org/nfhs/NFHS-4Reports/India.
  • Kahn BB, Flier JS. 2000. Obesity and insulin resistance. J Clin Invest. 106(4):473–481.
  • Kandasamy K, Rajagopal SS, Ramalingam K, Krishnan K. 2018. Assessment on prevalence of hypertension and its associated risk factors along with mmas score in a rural community: a home based screening. Asian J Pharm Clin Res. 11(8):337–341.
  • Kemche B, Saha Foudjo BU, Fokou E. 2020. Risk factors of hypertension among diabetic patients from Yaoundé Central Hospital and Etoug-Ebe Baptist Health Centre, Cameroon. J Diabetes Res. 2020:1853516.
  • Kim SJ, Kim DJ. 2012. Alcoholism and diabetes mellitus. Diabetes Metab J. 36(2):108–115.
  • Kosachunhanun N, Benjasuratwong Y, Mongkolsomlit S, Rawdaree P, Plengvidhya N, Leelawatana R, Bunnag P, et al. 2006. Thailand diabetes registry project: glycemic control in Thai type 2 diabetes and its relation to hypoglycemic agent usage. J Med Assoc Thai. 89(1):S66–S71.
  • Kotiso KS, Degemu N, Gebremedhin S, Taye M, Petros A, Belayneh F, Wolde D, Hailu D. 2021. Determinants of hypertension among patients with type 2 diabetes mellitus on follow-up at Tikur Anbessa Specialized Hospital, Addis Ababa: a case-control study. PLoS One. 16(8):e0256399.
  • Kotsis V, Stabouli S, Papakatsika S, Rizos Z, Parati G. 2010. Mechanisms of obesity-induced hypertension. Hypertens Res. 33(5):386–3893.
  • Lastra G, Syed S, Kurukulasuriya LR, Manrique C, Sowers JR. 2014. Type 2 diabetes mellitus and hypertension: an update. Endocrinol Metab Clin North Am. 43(1):103–122.
  • Lawes CM, Vander Hoorn S, Rodgers A. 2008. Global burden of blood-pressure-related disease, 2001. Lancet. 371(9623):1513–1518.
  • Lee HS, Lee SS, Hwang IY, Park YJ, Yoon SH, Han K, Son JW, Ko SH, et al. 2013. Prevalence, awareness, treatment and control of hypertension in adults with diagnosed diabetes: the Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV). J Hum Hypertens. 27(6):381–387.
  • Mallick A. 2021. Prevalence of low birth weight in India and its determinants: insights from the National Family Health Survey (NFHS), 2015–2016. Anthranz. 78(3):163–175.
  • Mansour AA. 2012. Prevalence and control of hypertension in Iraqi diabetic patients: a prospective cohort study. Open Cardiovasc Med J. 6(1):68–71.
  • Mayl JJ, German CA, Bertoni AG, Upadhya B, Bhave PD, Yeboah J, Singleton MJ. 2020. Association of alcohol intake with hypertension in type 2 diabetes mellitus: the ACCORD trial. J Am Heart Assoc. 9(18):e017334.
  • Mubarak FM, Froelicher ES, Jaddou HY, Ajlouni KM. 2008. Hypertension among 1000 patients with type 2 diabetes attending a national diabetes center in Jordan. Ann Saudi Med. 28(5):346–351.
  • Murray S. 2006. Poverty and health. CMAJ. 174(7):923.
  • Nouh F, Omar M, Younis M. 2017. Prevalence of hypertension among diabetic patients in Benghazi: a study of associated factors. Asian J Med Health. 6(4):1–11.
  • Ohishi M. 2018. Hypertension with diabetes mellitus: physiology and pathology. Hypertens Res. 41(6):389–393.
  • Okosun IS, Chandra KD, Choi S, Christman J, Dever GA, Prewitt TE. 2001. Hypertension and type 2 diabetes comorbidity in adults in the United States: risk of overall and regional adiposity. Obes Res. 9(1):1–9.
  • Otieno CF, Vaghela V, Mwendwa FW, Kayima JK, Ogola EN. 2005. Cardiovascular risk factors in patients with type 2 diabetes mellitus in Kenya: levels of control attained at the Outpatient Diabetic Clinic of Kenyatta National Hospital, Nairobi. East Afr Med J. 82(12):S184–S190.
  • Pandey AR, Karki KB, Mehata S, Aryal KK, Thapa P, Pandit A, Bista B, et al. 2015. Prevalence and determinants of comorbid diabetes and hypertension in Nepal: evidence from non communicable disease risk factors STEPS Survey Nepal 2013. J Nepal Health Res Counc. 13(29):20–25.
  • Patel R, Chauhan S. 2020. Gender differential in health care utilisation in India. Clin Epidemiol Glob Health. 8(2):526–530.
  • Piano MR. 2017. Alcohol’s effects on the cardiovascular system. Alcohol Res. 38(2):219–241.
  • Pinto E. 2007. Blood pressure and ageing. Postgrad Med J. 83(976):109–114.
  • Prabhakaran D, Jeemon P, Roy A. 2016. Cardiovascular diseases in India: current epidemiology and future directions. Circulation. 133(16):1605–1620.
  • Rahman M, H SE, Islam MJ, Mostofa MG, Saadat KA. 2015. Association of socioeconomic status with diagnosis, treatment and control of hypertension in diabetic hypertensive individuals in Bangladesh: a population-based cross-sectional study. JRSM Open. 6(10):2054270415608118.
  • Roerecke M, Tobe SW, Kaczorowski J, Bacon SL, Vafaei A, Hasan OS, Krishnan RJ, et al. 2018. Sex‐specific associations between alcohol consumption and incidence of hypertension: a systematic review and meta‐analysis of cohort studies. J Am Heart Assoc. 7(13):e008202.
  • Roy SK. 1991. Health status of oraon tea garden labourers. Indian J Soc Work. 52(3):369–377.
  • Safar ME. 2005. Systolic hypertension in the elderly: arterial wall mechanical properties and the renin-angiotensin-aldosterone system. J Hypertens. 23(4):673–681.
  • Saju MD, Allagh KP, Scaria L, Joseph S, Thiyagarajan JA. 2020. Prevalence, awareness, treatment, and control of hypertension and its associated risk factors: results from baseline survey of SWADES family cohort study. Int J Hypertens. 2020:4964835.
  • Sami W, Ansari T, Butt NS, Hamid MRA. 2017. Effect of diet on type 2 diabetes mellitus: a review. Int J Health Sci (Qassim). 11(2):65–71.
  • Sasaki N, Ozono R, Higashi Y, Maeda R, Kihara Y. 2020. Association of insulin resistance, plasma glucose level, and serum insulin level with hypertension in a population with different stages of impaired glucose metabolism. J Am Heart Assoc. 9(7):e015546.
  • Seravalle G, Grassi G. 2016. Sympathetic nervous system, hypertension, obesity and metabolic syndrome. High Blood Press Cardiovasc Prev. 23(3):175–179.
  • Shrestha UK, Singh DL, Bhattarai MD. 2006. The prevalence of hypertension and diabetes defined by fasting and 2‐h plasma glucose criteria in urban Nepal. Diabetic Med. 23(10):1130–1135.
  • Sprafka JM, Bender AP, Jagger HG. 1988. Prevalence of hypertension and associated risk factors among diabetic individuals. The three-city study. Diabetes Care. 11(1):17–22.
  • Tadesse K, Amare H, Hailemariam T, Gebremariam T. 2018. Prevalence of hypertension among patients with type 2 diabetes mellitus and its socio demographic factors in Nigist Ellen Mohamed Memorial Hospital Hosanna, Southern Ethiopia. J Diabetes Metab. 09(04):4–10.
  • Tareque MI, Koshio A, Tiedt AD, Hasegawa T. 2015. Are the rates of hypertension and diabetes higher in people from lower socioeconomic status in Bangladesh? Results from a nationally representative survey. PLoS One. 10(5):e0127954.
  • Tatsumi Y, Ohkubo T. 2017. Hypertension with diabetes mellitus: significance from an epidemiological perspective for Japanese. Hypertens Res. 40(9):795–806.
  • Taylor B, Irving HM, Baliunas D, Roerecke M, Patra J, Mohapatra S, Rehm J. 2009. Alcohol and hypertension: gender differences in dose-response relationships determined through systematic review and meta-analysis. Addiction. 104(12):1981–1990.
  • Tiptaradol S, Aekplakorn W. 2012. Prevalence, awareness, treatment and control of coexistence of diabetes and hypertension in Thai population. Int J Hypertens. 2012:386453.
  • Tripathy JP, Thakur JS, Jeet G, Jain S. 2017. Prevalence and determinants of comorbid diabetes and hypertension: evidence from non communicable disease risk factor STEPS survey, India. Diabetes Metab Syndr. 11:S459–S65.
  • Tseng CH. 2006. Higher risk of hypertension in indigenous type 2 diabetic patients in Taiwan. J Hypertens. 24(9):1817–1821.
  • Tsimihodimos V, Gonzalez-Villalpando C, Meigs JB, Ferrannini E. 2018. Hypertension and diabetes mellitus: coprediction and time trajectories. Hypertension. 71(3):422–428.
  • Unadike BC, Eregie A, Ohwovoriole AE. 2011. Prevalence of hypertension amongst persons with diabetes mellitus in Benin City, Nigeria. Niger J Clin Pract. 14(3):300–302.
  • Vijayakumar G, Manghat S, Vijayakumar R, Simon L, Scaria LM, Vijayakumar A, Sreehari GK, et al. 2019. Incidence of type 2 diabetes mellitus and prediabetes in Kerala, India: results from a 10-year prospective cohort. BMC Public Health. 19(1):140.
  • Virdis A, Giannarelli C, Fritsch Neves M, Taddei S, Ghiadoni L. 2010. Cigarette smoking and hypertension. Curr Pharm Des. 16(23):2518–2525.
  • Whelton PK, Carey RM, Aronow WS, Casey DE, Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, et al. 2018. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 71(19):e127–e248.
  • WHO. 2011. Global status report on noncommunicable diseases 2010. Geneva, Switzerland: World Health Organization. [accessed Oct 25]. https://apps.who.int/iris/handle/10665/44579.
  • WHO. 2020. Hypertension. Geneva, Switzerland: World Health Organization. [accessed Oct 25]. https://www.who.int/news-room/fact-sheets/detail/hypertension.
  • WHO. 2021. The top 10 causes of death. Geneva, Switzerland: World Health Organization. [accessed Nov 02]. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death.
  • Yadav S, Arokiasamy P. 2014. Understanding epidemiological transition in India. Glob Health Action. 7:23248.
  • Zafari N, Asgari S, Lotfaliany M, Hadaegh A, Azizi F, Hadaegh F. 2017. Impact of hypertension versus diabetes on cardiovascular and all-cause mortality in Iranian older adults: results of 14 years of follow-up. Sci Rep. 7(1):14220.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.